Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Phivida Launches Premium CBD Extracts, Beverages and Wholesale Hemp Oil
  • USA - English


News provided by

Phivida Organics Inc.

Nov 30, 2016, 10:35 ET

Share this article

Share toX

Share this article

Share toX


Los Angeles, CA (PRWEB) November 30, 2016 -- With the successful passing of legalization in California, Phivida Inc. has officially launched their premium line of Hemp Oil products into the USA health and wellness marketplace. Phivida products are now available online at phivida.com and coming soon to a national network of retail distribution across the USA.

Phivida launches during a momentous, yet turbulent era in US political history, with the election of a new president and nine states voting for the legalization of cannabis.

Post this

Phivida Hemp Oil extracts and infusions contain naturally occurring cannabinoids (e.g. Cannabidiol, or CBD) in a range of consumer product formats. Using legally imported Hemp Oil extract, instead of federally illegal cannabis, Phivida offers American families with access to the key cannabinoids found in medicinal cannabis, without the psychoactive side effects of THC and the legal restrictions of a standing federal ban on marijuana.

Phivida launches during a momentous, yet turbulent era in US political history, with the election of a new president and nine states voting for the legalization of cannabis. California, Massachusetts, Maine and Nevada have all legalized recreational cannabis. In addition, Canada‘s cannabis legalization taskforce is expected to announce the new program framework later this month, and a rollout in 2017. Arkansas, Florida, Montana and North Dakota have also voted to legalize medical cannabis for use in debilitating diseases.  Advocates say this new government sponsorship of cannabis health encourages increased public access, education and awareness of cannabinoids and puts pressure on Congress, and other federal agencies, to act.

Many are calling this the end of Prohibition in North America, however, none of these newly legalized states change the current US federal ban on cannabis. The reality is that each state is highly regulated and taxed and will be restricted to intrastate distribution through a limited network of dispensaries. Even with this strict state level governance and regulation, many cite the lack of testing and quality control standards within these channels, and the lack of alternative access to non-psychoactive cannabinoids, such as those found in hemp oil.

In addition, skeptics of the parallel hemp oil industry cite poor production and quality control standards. Many CBD companies have been reprimanded by the FDA and other authorities for consumer safety, compliance and mislabeling infractions. Conversely, Phivida provides consumers with a premium quality alternative, and the peace of mind of knowing their families’ cannabinoid products are safe, and contain the highest quality ingredients available.

Phivida proudly serves American families, patients, caregivers and health care practitioners with Hemp Oil extracts naturally refined from 100% certified organic hemp. All Phivida Hemp Oil extracts are laboratory tested for safety, quality and potency, and bottled in clinical grade packaging with FDA compliant labeling, made in the USA at cGMP certified manufacturing facilities. Phivida products are doctor formulated using special blends of premium botanical based Nutraceuticals, targeting key health conditions. Maintaining the highest quality standards – Phivida products are designed for distribution into national chains of natural health stores, clinics, vitamin shops and specialty grocery stores, and now online at: http://www.phivida.com.  

Despite aging baby boomers, epidemic levels of inflammation based disorders, and growing public support, medical cannabis remains federally illegal. On the other hand, Phivida provides safe alternative access to non-psychoactive cannabinoids from import Hemp Oil extract; free from political risk, public controversy, and the side-effects of THC.

Hemp Oil Beverages

Phivida is dedicated to innovation in the functional foods and natural health product sector, a global market estimated at over $1 Trillion USD. Using cutting edge nano-encapsulation technology, Phivida has the ability to produce water soluble Hemp Oils, used to produce a custom formulated line of infused functional beverages. All beverages are 100% vegan, low calorie, with no added sugar, no artificial flavors or colors, and are free of; gluten, soy and tree nuts. Phivida Hemp Oil infused beverages are Non-GMO, made with organic ingredients such as natural fruit juices, as well as a special doctor formulated blend of botanical vitamins, minerals, electrolytes and other nutraceuticals targeting specific health conditions and performance. Phivida functional beverage product lines include; Iced Teas formulated for GI and Gut Health, Vitamin Juices for cognition, immune system and mood, and Nutritional Shakes for muscle, bone and joints. Visit http://www.phivida.com for more information.

Hemp Oil (and CBD)

Phivida Hemp Oil extracts have gained popularity from the burgeoning global medical cannabis sector as they contain naturally occurring cannabinoids, such as “Cannabidiol” (CBD). Cannabidiol from hemp oil has been the focus of much media attention in recent years due to the hundreds of clinical trials at the top medical research centers in the world, exploring the potential of CBD in the clinical treatment of all 20 of the top therapeutic categories (an estimated $200B USA market). Such clinical trials include; pain and inflammation, Cancer, Diabetes, Epilepsy, Parkinson's, Multiple Sclerosis, Alzheimer's, Crohns and Colitis and other major diseases and disorders. Popularized by the medicinal cannabis lobby, Cannabidiol is also found in high concentration within Hemp Oil extracts, free of THC and when legally imported, is eligible for sale in all 50 states and retail channels.

For more information on the potential of Hemp Oil extract and its cannabinoids, such as Cannabidiol please visit pubmed.gov and search “Cannabidiol”.

About Phivida Inc.

Phivida Inc. advocates a return to traditional whole plant medicine, celebrating; Health and Wellness, In Harmony™. Phivida’s mission is to be a leader in the alternative wellness sector – specializing in premium Hemp Oil extracts. Phivida is dedicated to the highest quality standards and only uses premium organic ingredients, professionally formulated, third party tested for safety, purity and potency and manufactured at cGMP certified facilities. Partnered with some the largest certified organic hemp farms in Europe, Phivida also offers wholesale Hemp Oil extract in bulk in a number of formats including: nano-encapsulation technology for enhanced bioavailability and water solubility for use in any beverage format, including their Hemp Oil infused functional beverages, the retail market shelves in 2017.

For more information on Phivida, visit http://www.phivida.com or call toll-free: 1-844-744-6646.  

------
This press release may contain “forward-looking statements”, “forward-looking information” and “future-oriented financial information” (collectively herein referred to as “forward looking statements” within the meaning of applicable securities laws. Phivida Organics Inc. (the “Subsidiary”) and the parent company Phytofarms Holdings Inc. (the “Company”) are providing cautionary statements identifying important factors that could cause the Company’s actual results to differ materially and significantly from those projected in these forward-looking statements, including information regarding the Company’s revenue; profit margins; and proposed share structure. The words “anticipate”, “expect”, “believe”, “attempt”, "may", "could", "should", “ensure”, "estimate", "plan", "project", “strategy”, "intend", "outlook", “strive”, "forecast", "likely", "probably" or other similar words are used to identify forward-looking information.   Such statements represent the Company’s internal projections, estimates, expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance.  These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, no assurance can be given that these expectations will prove to be correct and such forward-looking statements should not be unduly relied upon.  Many factors could cause the Company’s actual results to differ materially from those expressed or implied in any forward-looking statements made by, or on behalf of, the Company.  Such forward-looking information may relate to, without limitation: the future activities and performance of the Company; the value of the Company’s common shares; the technological development of the Company; estimates relating to the amount of funds available to the Company; volatile securities markets; and the manner in which such funds will be used. Additional factors that could cause actual results to differ from the Company’s expectations include, but are not limited to: the Company’s ability to launch its products in an efficient manner; competition; legal requirements and limitations and the possibility that the law relating to the Company’s business could change in a manner that materially adversely affects the Company’s business; the Company’s ability to enter into advantageous agreements and business relationships; the Company’s ability to attract customers for its products; general economic conditions and those economic conditions specific to the hemp and cannabinoid industry; the Company’s ability to innovate and improve monetization; the growth of the market for hemp and cannabinoid products; the Company’s ability to reach a broad consumer base; the Company’s ability to expand to different cities nationally and internationally; geopolitical events such as war, threat of war or terrorist activities; as well as any specific risk factors discussed in this presentation.

This does not constitute an offer to sell or the solicitation of an offer to buy any securities of the Company in any jurisdiction in which such offer or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease. Always check with your physician before starting a new dietary supplement or nutrition program.

*Cannabidiol (CBD) is a natural constituent of hemp oil.

We seek safe harbor.

Kyle Johnston, Phivida Organics Inc., http://phivida.com, +1 310-359-8947, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.